Your browser doesn't support javascript.
loading
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.
Jackisch, Christian; Hegg, Roberto; Stroyakovskiy, Daniil; Ahn, Jin-Seok; Melichar, Bohuslav; Chen, Shin-Cheh; Kim, Sung-Bae; Lichinitser, Mikhail; Staroslawska, Elzbieta; Kunz, Georg; Falcon, Silvia; Chen, Shou-Tung; Crepelle-Fléchais, Aulde; Heinzmann, Dominik; Shing, Mona; Pivot, Xavier.
Affiliation
  • Jackisch C; Sana Klinikum Offenbach GmbH, Department of Obstetrics and Gynecology & Breast Cancer and Gynecology Cancer Center, Starkenburgring 66, D-63069, Offenbach, Germany. Electronic address: christian.jackisch@sana.de.
  • Hegg R; Hospital Pérola Byington and FMUSP, Department of Gynecology and Obstetrics, Avenida Brigadeiro Luís Antônio, 683 - Bela Vista, São Paulo - SP, 01317-000, Brazil.
  • Stroyakovskiy D; City Clinical Oncology Hospital 62, Chemotherapeutic Department, Moscow, 143423, Russia.
  • Ahn JS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, South Korea.
  • Melichar B; Palacký University Medical School & Teaching Hospital, Department of Oncology, I. P. Pavlova 185/6, 779 00, Olomouc, Czech Republic.
  • Chen SC; Chang Gung Memorial Hospital, Department of Surgery, No. 123, Dinghu Rd, Guishan District, Taoyuan, Taiwan.
  • Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Department of Oncology, 88 Olympic-ro, 43-gil, Songpa-gu, Seoul, South Korea.
  • Lichinitser M; NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoye Shosse 24, 115478, Moscow, Russia.
  • Staroslawska E; St. John's Cancer Center, 20-090, Lublin, Poland.
  • Kunz G; St. Johannes Hospital, Johannesstraße 9-13, 44137, Dortmund, Germany.
  • Falcon S; Hospital Nacional Edgardo Rebagliati Martins, Av. Rebagliati 490, Jesús María, Lima 11, Peru.
  • Chen ST; Changhua Christian Hospital, No. 135, Nanhsiao St, Changhua City, Changhua County, Taiwan.
  • Crepelle-Fléchais A; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
  • Heinzmann D; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
  • Shing M; Genentech, Inc., Global Pharma Development, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Pivot X; CHU Jean Minjoz, Chemotherapy - Oncology, 3 Boulevard Alexandre Fleming, 25030, Besançon, France.
Eur J Cancer ; 62: 62-75, 2016 07.
Article in En | MEDLINE | ID: mdl-27208905
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Trastuzumab / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2016 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Trastuzumab / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2016 Document type: Article Country of publication: Reino Unido